Naoto Fujiwara

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 27 papers. Top paper: “Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development”.

Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development

Gastroenterology(2021)10.1053/j.gastro.2021.12.250

N/A

2.3DataRank · unranked

40 citations

Naoto Fujiwara, Bhuvaneswari Koneru, Atsushi Ono, Naoto Kubota, Arun Kumar Jajoriya +54 more

A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery

Nature Communications(2021)10.1038/s41467-021-25468-9

N/A

1.1DataRank · unranked

41 citations

Simonetta Bandiera, Naoto Fujiwara, Shen Li, Hussein El Saghire, Mirian Fernández-Vaquero +63 more

Endogenous renal adiponectin drives gluconeogenesis through enhancing pyruvate and fatty acid utilization

Nature Communications(2023)10.1038/s41467-023-42188-4

N/A

1.1DataRank · unranked

38 citations

May-Yun Wang, Joseph M. Rutkowski, Stanisław Deja, Shiuhwei Chen, Michael S. Balzer +19 more

Cost-effectiveness of a precision hepatocellular carcinoma surveillance strategy in patients with cirrhosis

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102755

N/A

0.538DataRank · unranked

35 citations

Kinpritma Sangha, Naoto Fujiwara, Yujin Hoshida, Neehar D. Parikh, Amit G. Singal +1 more

Master Transcription Factor Reprogramming Unleashes Selective Translation Promoting Castration Resistance and Immune Evasion in Lethal Prostate Cancer

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0306

N/A

0.470DataRank · unranked

22 citations

Shijia Zhu, Vijayakumar Jawalagatti, Marc Carceles-Cordon, Adam Ertel, Saioa Garcia‐Longarte +20 more

A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor

Nature Communications(2020)10.1038/s41467-020-16517-w

N/A

0.464DataRank · unranked

21 citations

Laura Heydmann, Che C. Colpitts, Houssein El Saghire, Federica Piccioni, Frank Jühling +18 more

A Blood-Based Prognostic Liver Secretome Signature Predicts Long-term Risk of Hepatic Decompensation in Cirrhosis

Clinical Gastroenterology and Hepatology(2021)10.1016/j.cgh.2021.03.019

N/A

0.396DataRank · unranked

13 citations

Austin J. Fobar, Indu Raman, Quan‐Zhen Li, Jorge A. Marrero, Neehar D. Parikh +3 more

Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic

Hepatology(2025)10.1097/hep.0000000000001227

N/A

0.366DataRank · unranked

10 citations

Naoto Fujiwara, Amit G. Singal, Thomas F. Baumert, Raymond T. Chung, Takumi Kawaguchi +2 more

Viral Exposure Signature Associated with Liver Cancer Risk

Trends in Molecular Medicine(2020)10.1016/j.molmed.2020.06.008

N/A

0.208DataRank · unranked

3 citations

Yujin Hoshida, Naoto Fujiwara

Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver disease

eGastroenterology(2025)10.1136/egastro-2024-100159

N/A

0.208DataRank · unranked

3 citations

Frank Jühling, Julien Moehlin, Laurent Mailly, Alessia Virzì, Nicolas Brignon +27 more

Liver cancer risk-predictive molecular biomarkers specific to clinico-epidemiological contexts

Advances in cancer research(2022)10.1016/bs.acr.2022.01.005

N/A

0.165DataRank · unranked

2 citations

Naoto Fujiwara, Yujin Hoshida, Naoto Kubota

Research Communication: Serum Metabolomic Signatures Predict Tumour Recurrence After Resection or Ablation in Patients With Early‐Stage Hepatocellular Carcinoma

Alimentary Pharmacology & Therapeutics(2025)10.1111/apt.70355

N/A

0.104DataRank · unranked

1 citations

Hiroaki Kanzaki, Fouzia Ahmed, Naoto Fujiwara, Yujin Hoshida, Amit G. Singal +1 more

Targeting peroxiredoxin 2 prevents hepatocarcinogenesis in metabolic liver disease models

Journal of Clinical Investigation(2025)10.1172/jci169395

N/A

0.104DataRank · unranked

1 citations

Eugénie Schaeffer, Marine A. Oudot, Julien Moehlin, Cloé Gadenne, Frank Jühling +26 more

Reply

Gastroenterology(2025)10.1053/j.gastro.2025.04.016

N/A

0.104DataRank · unranked

1 citations

Amit G. Singal, Yujin Hoshida, Naoto Fujiwara

A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis

Med(2021)10.1016/j.medj.2021.03.017

N/A

0DataRank · unranked

57 citations

Masahiro Kobayashi, Austin J. Fobar, Ayaka Hoshida, Cesia A. Marquez, Bhuvaneswari Koneru +20 more

Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma

Liver International(2020)10.1111/liv.14560

N/A

0DataRank · unranked

45 citations

Chia‐Yang Hsu, Chien‐Wei Su, Yi‐Hsiang Huang, Ming‐Chih Hou, Nicole E. Rich +5 more

Disseminative Recurrence Signature for Hepatocellular Carcinoma From Nonalcoholic Fatty Liver Disease

Gastro Hep Advances(2023)10.1016/j.gastha.2023.03.021

N/A

0DataRank · unranked

6 citations

Naoto Kubota, Shijia Zhu, Shigeki Nakagawa, Hideo Baba, Yujin Hoshida +1 more

Deep-Learning-Based Hepatic Ploidy Quantification Using H&E Histopathology Images

Genes(2023)10.3390/genes14040921

N/A

0DataRank · unranked

5 citations

Yu-Hsuan Lin, Shidan Wang, Naoto Fujiwara, Ruichen Rong, Kevin W. Jin +9 more

Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.20.533505

N/A

0DataRank · unranked

10 citations

Shijia Zhu, Yuemeng Jia, Yunguan Wang, Naoto Kubota, Naoto Fujiwara +14 more

Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis

Nature(2022)10.1038/s41586-022-05289-6

N/A

0DataRank · unranked

336 citations

Yoshinobu Saito, Ajay Nair, Dianne H. Dapito, Le‐Xing Yu, Aashreya Ravichandra +33 more

PKD1 mutant clones within cirrhotic livers inhibit steatohepatitis without promoting cancer

Cell Metabolism(2024)10.1016/j.cmet.2024.05.015

N/A

0DataRank · unranked

9 citations

Yunguan Wang, Tianshi Lü, Jason Guo, Lin Li, Meng-Hsiung Hsieh +15 more

The Spatial Extracellular Proteomic Tumor Microenvironment Distinguishes Molecular Subtypes of Hepatocellular Carcinoma

Journal of Proteome Research(2024)10.1021/acs.jproteome.4c00099

N/A

0DataRank · unranked

7 citations

Harrison Taylor, Mengjun Wang, Andrew DelaCourt, Christin Edge, David Lewin +16 more

Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma

Gut(2020)10.1136/gutjnl-2019-318918

N/A

0DataRank · unranked

96 citations

Nourdine Hamdane, Émilie Crouchet, Li Shen, Houssein El Saghire, Atish Mukherji +27 more

A human liver cell-based system modeling a clinical prognostic liver signature combined with single cell RNA-seq for discovery of novel liver disease therapeutics

Journal of Hepatology(2020)10.1016/s0168-8278(20)30611-5

N/A

0DataRank · unranked

0 citations

Simonetta Bandiera, Naoto Fujiwara, Shen Li, Hussein El Saghire, Xiaochen Sun +62 more

Clinical and Molecular Prediction of Hepatocellular Carcinoma Risk

Journal of Clinical Medicine(2020)10.3390/jcm9123843

N/A

0DataRank · unranked

18 citations

Naoto Fujiwara, Yujin Hoshida, Naoto Kubota

Risk stratification and early detection biomarkers for precision HCC screening

Hepatology(2022)10.1002/hep.32779

N/A

0DataRank · unranked

115 citations

Naoto Fujiwara, Ju Dong Yang, Yujin Hoshida, Yi‐Te Lee

Plasma-Signature-Model for End-Stage Liver Disease Score to Predict Survival in Severe Alcoholic Hepatitis

Clinical Gastroenterology and Hepatology(2021)10.1016/j.cgh.2021.02.041

N/A

0DataRank · unranked

9 citations

Eric Trépo, Indu Raman, Quan‐Zhen Li, Delphine Degré, Thierry Gustot +3 more